Skip to main content
. 2022 Mar 9;3(4):100307. doi: 10.1016/j.jtocrr.2022.100307

Figure 1.

Figure 1

Multivariable model forest plot of sex differences in time to treatment, time of treatment, and complications after treatment for lung cancer, UH database, 2005 to 2020. The ORs are calculated for female patients. (1) Adjusted for age at diagnosis, smoking status, histology, Charlson score, stage, and surgery. (2) Adjusted for race, smoking status, histology, surgery, Charlson score, stage, and chemotherapy. (3) Adjusted for age at diagnosis, stage, chemotherapy, and immunotherapy. (4) Adjusted for age at diagnosis, subhistology. (5) Adjusted for age at diagnosis, Charlson score, stage, chemotherapy, and immunotherapy. (6) Adjusted for smoking status, Charlson score, stage, chemotherapy, immunotherapy, and surgery. (7) Adjusted for age at diagnosis, histology, surgery, stage, and immunotherapy. (8) Adjusted for age at diagnosis, smoking status, histology, Charlson score, stage, chemotherapy, and surgery. (9) Adjusted for age at diagnosis, Charlson score, and chemotherapy. (10) Adjusted for histology, stage, chemotherapy, and immunotherapy. (11) Adjusted for ethnicity, histology, stage, chemotherapy, and immunotherapy. H95, higher 95% confidence interval; HR, hazard ratio; irAE, immune-related adverse event; L95, lower 95% confidence interval; UH, University Hospital.